New drug combo shows promise for spreading vitiligo
NCT ID NCT04822584
First seen May 16, 2026 · Last updated Jun 12, 2026 · Updated 4 times
Summary
This study tested whether adding the drug baricitinib to light therapy helps adults with active, spreading vitiligo regain skin color. About 49 participants received either the combination or light therapy alone for 12 weeks. The main goal was to measure changes in the amount of affected skin using a standard scoring system.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Universitaire de Nice - Service de Dermatologie
Nice, 06000, France
-
Service de Dermatologie - Hôpital Saint-André
Bordeaux, Bordeaux, 33075, France
-
Service de dermatologie - Hôpital Henri Mondor - EA EpiDermE (Epidémiologie en Dermatologie et Evaluation des Thérapeutiques)
Créteil, 94010, France
-
Service de dermatologie Centre de Référence des Maladies Rares de la Peau et des muqueuses d'origine génétique - Hôpital Larrey
Toulouse, 31059 cedex 9, France
Conditions
Explore the condition pages connected to this study.